APA (7th ed.) Citation

KL, V., JA, M., MA, M., CW, H., PA, A., M, G., . . . MM, B. (2018). Phase I trial of pod-intravaginal rings delivering antiretroviral agents for HIV-1 prevention: Rectal drug exposure from vaginal dosing with tenofovir disoproxil fumarate, emtricitabine, and maraviroc. PloS one, 13(8), e0201952. https://doi.org/10.1371/journal.pone.0201952

Chicago Style (17th ed.) Citation

KL, Vincent, et al. "Phase I Trial of Pod-intravaginal Rings Delivering Antiretroviral Agents for HIV-1 Prevention: Rectal Drug Exposure from Vaginal Dosing with Tenofovir Disoproxil Fumarate, Emtricitabine, and Maraviroc." PloS One 13, no. 8 (2018): e0201952. https://doi.org/10.1371/journal.pone.0201952.

MLA (9th ed.) Citation

KL, Vincent, et al. "Phase I Trial of Pod-intravaginal Rings Delivering Antiretroviral Agents for HIV-1 Prevention: Rectal Drug Exposure from Vaginal Dosing with Tenofovir Disoproxil Fumarate, Emtricitabine, and Maraviroc." PloS One, vol. 13, no. 8, 2018, p. e0201952, https://doi.org/10.1371/journal.pone.0201952.